Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Graft-versus-host disease | R-HSA-1643685 | map05332 | cyclizine | 6726 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | cyclizine | 6726 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | cyclizine | 6726 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | cyclizine | 6726 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | cyclizine | 6726 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | cyclizine | 6726 | drug-path |
Asthma | R-HSA-444620 | map05310 | cyclizine | 6726 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | cyclizine | 6726 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | cyclizine | 6726 | drug-path |
Glioma | Q9NZM4 | map05214 | cyclizine | 6726 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | cyclizine | 6726 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | cyclizine | 6726 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | cyclizine | 6726 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | cyclizine | 6726 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | cyclizine | 6726 | drug-path |
Adherens junction | R-HSA-451386 | map04520 | cyclizine | 6726 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | cyclizine | 6726 | drug-path |
Circadian rhythm - mammal | R-HSA-400253 | 0 | cyclizine | 6726 | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | cyclizine | 6726 | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | cyclizine | 6726 | drug-path |